A Phase 1, Randomized, Double-Blind Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of an Accelerated Vaccination Schedule With a Zika Virus Purified Inactivated Vaccine Plus Alum Adjuvant in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 30 Aug 2018
At a glance
- Drugs Zika virus vaccine-Sanofi (Primary)
- Indications Zika virus infection
- Focus Adverse reactions
- 22 Aug 2018 Status changed from active, no longer recruiting to completed.
- 29 May 2018 Planned primary completion date changed from 1 Mar 2018 to 1 Jul 2018.
- 22 Dec 2017 Planned End Date changed from 1 Apr 2018 to 1 Aug 2018.